• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Stock Trend Alerts

Essential Market Ideas and Investing Strategies

  • Newsletter Reviews
  • Hot Stocks
  • Technology
  • Financial News
  • Secrets of the Pros
  • Analysis
Home » How to Find Biotech Stocks with Huge Profit Potential

How to Find Biotech Stocks with Huge Profit Potential

I got involved in the biotech sector in 2004 because I realized that no other sector had the same potential for enormous gains and sustained growth.

You’ve probably heard the stats by now. Ten thousand baby boomers turn 65 every day in the United States. And what do we consume more of as we get older? Healthcare.

As we advance in our senior years, more people get sick and require more medicines for difficult-to-treat diseases.

So if I could invest in only one sector for the next five or 10 years, it would be biotech. But how do you choose which ones to invest in?

As The Oxford Club’s resident biotech expert, I’m often asked what I look for when choosing biotech stocks.

Here are some of the things I want to see:

Game-changing technology.

I’m not interested in a company that has a cancer drug that adds two months of life over the existing standard of care. I want to see entirely new approaches to treating disease – something we’ve never seen before.

[Breakthrough Alert: The Liquid in this Vial Can Treat All 6,000 Genetic Diseases…Combined!]

Safety.

A drug is unlikely to get approved if it is unsafe, no matter how effective it is. I pay particularly close attention to Phase 2 trial results because that’s usually the first real indication of whether a drug is safe enough to try in a larger population.

Upcoming catalysts.

Biotech stocks can move quickly on news. I don’t want to be sitting with a stock for a year and a half waiting for clinical trial results. I typically want to see important trial data within six months.

Cash on the books.

Most small cap biotech companies are unprofitable and burn cash. I’d rather not be holding the stock when management sells shares to raise capital. This dilutes existing shareholders and causes the stock to drop. If the company has a lot of cash already, it reduces the chance of seeing a stock offering.

Smart money.

I like to see investors who I respect own large holdings in the stock. When I see investors like Felix and Julian Baker or others, I know some major league brainpower has reviewed the company’s science and investment opportunity ahead of me and has decided to move forward. My confidence is also boosted when insiders own a lot of shares.

[Discover: Why Big Pharma Firms have Invested Over $1 Billion into this Tiny Biotech]

From there, I’ll dig into the clinical trials, investigate management to see whether there are any red flags and conduct other due diligence.

There are a lot of factors that go into deciding to pull the trigger on a biotech stock, but the above list is a good start.

Remember, no other sector sees stocks move 50% or even more than 100% in a day on a takeover announcement.

Five Prime Therapeutics (Nasdaq: FPRX) was up 78% in one day in March on an acquisition announcement – and that was after it jumped 349% in one day in November after reporting positive data.

I would argue that biotech is the most important sector in the market and will be for the next five to 10 years and beyond. Your portfolio should have some exposure to it in order to take advantage of the enormous potential.

Good investing,

Marc

[Exclusive: Turn $1,000 into $1.57 Million – with “The Holy Grail of Medicine”]

Read more from Marc Lichtenfeld at WealthyRetirement.com

You Might Also Like...

  • The 4 Top Artificial Intelligence Stocks as Demand Continues to Soar
  • 3 Top Infrastructure Stocks Set to Benefit from Massive Bill
  • Three Penny Stocks to Add to Your Watchlist in 2022
  • 3 Diverse Penny Stocks with Major Gain Potential...

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Primary Sidebar

Subscribe to Stock Trend Alerts

By submitting your email address, you give Stock Trend Alerts permission to deliver investment research to your email inbox. Privacy Policy | How It Works

Popular Posts

  • Martin Weiss Docket No. OP–1670: 12 Inflation-Beating Stocks
  • Jim Rickards – The Return of American Energy: Profit from the Green Lie
  • Andrew Zatlin: Biden’s Puppet Master Exposed and How to Opt Out of the Digital Dollar
  • Why 2023 Could Kick Off a “Cash Frenzy” in Stocks
  • Dylan Jovine 21st Century Battlefield: 4 Companies Changing Warfare
  • Infinite Energy Stock: The Tiny Company Dominating Tesla in the Trillion-Dollar Green Energy Race
  • Dylan Jovine Search & Destroy: 3 AI Software Stocks Revolutionizing Warfare
  • BREAKING: Military to spend billions on “Living Missile”

Recent Posts

  • 25 Super-Woke Companies You Do Not Want in Your Portfolio with Alexander Green
  • Jeff Clark Trader: The Currency Trading Retirement Blueprint
  • Jason Williams Blue Gas: The Tesla Killer Fuel Cell Revolution
  • Andrew Zatlin: Biden’s Puppet Master Exposed and How to Opt Out of the Digital Dollar
  • The AI Takeover: Jason Bodner’s Quantum Edge Trader Smart Tech

Topics

AAPL Advertorial Amazon AMZN Artificial Intelligence Battery Bear Market Biotech Bitcoin Blockchain Clean Energy Cloud Computing Coronavirus COVID Creative Cryptocurrency Dividends E-Commerce Electric Vehicles Elon Musk Energy Ethereum Gold Growth Stocks Inflation Interest Rates International Jeff Brown Louis Navellier Market Crash MSFT Oil and Gas Options Prediction President Biden Recession Retirement Russia Semiconductor Supply Chain Tesla The Fed TSLA Volatility Warren Buffett

Copyright © 2023 · Stock Trend Alerts - Essential Market Moves and Investing Ideas

Nothing on this website should be considered personalized financial advice. Any investments recommended here in should be made only after consulting with your personal investment advisor and only after performing your own research and due diligence, including reviewing the prospectus or financial statements of the issuer of any security.

Stock Trend Alerts, its managers, its employees, affiliates and assigns (collectively "The Company") do not make any guarantee or warranty about the advice provided on this website or what is otherwise advertised above.

The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. The Company is not affiliated with, nor does it receive compensation from, any specific security.

To the maximum extent permitted by law, the Company disclaims any and all liability in the event any information, commentary, analysis, opinions, advice and/or recommendations provided herein prove to be inaccurate, incomplete or unreliable, or result in any investment or other losses.

About Us | How it Works | Privacy Policy | Terms and Conditions | Contact Us